Mortality from Late Central Nervous System Effects Among US Astronauts 1959-2022

Space travel pushes the human body to its absolute limits, exposing astronauts to hazards that never exist on Earth. Among the most persistent and invisible threats is radiation. Unlike the brief, intense bursts of radiation from solar flares, deep space is filled with a constant, low-level stream of high-energy particles that can penetrate spacecraft hulls and human tissue. While scientists have long worried about how this radiation might cause cancer or heart disease decades later, a newer and more complex concern has emerged: the potential for these particles to damage the central nervous system. This includes the slow, progressive decline of the brain seen in conditions like Alzheimer's disease and dementia. For NASA, understanding whether spaceflight accelerates these neurological problems is critical. Before humans can safely journey to the Moon or Mars, where radiation exposure will be far greater than in low Earth orbit, researchers must know if the current generation of astronauts is already showing signs of this hidden damage.

To answer this, a team of researchers led by Robert J. Reynolds analyzed the entire history of NASA astronauts from the program's beginning in 1959 through 2022. They did not look at brain scans or memory tests, but rather at the ultimate outcome: death records. By linking a database of astronaut biographical details with national mortality records, they searched for deaths specifically caused by late effects on the central nervous system, such as dementia and motor neuron disease. The goal was to see if these astronauts died from these conditions at a higher rate than the average American of the same age and gender. The study covered 299 male astronauts and 61 female astronauts, tracking them for an average of over 30 years.

The results of this long-term look back were surprisingly quiet. Among the male astronauts, only two deaths were attributed to late central nervous system effects over the entire period. Statistically, the researchers expected to see about five deaths in a group of this size and age if they were at the same risk as the general public. This means the observed number was actually lower than expected, suggesting the astronauts might not be at increased risk. However, because the total number of deaths was so small, the researchers could not say with certainty that the risk was lower, nor could they rule out that it might be higher. The data was simply too sparse to draw a sharp line. For the female astronauts, the picture was even more unclear; no deaths from these causes were observed, but the group was so small and the follow-up time so short that the statistical margin of error was enormous. In short, the study found no evidence of a crisis, but it also could not prove that the risk is zero.

Recognizing that waiting for more deaths to happen is not a practical way to manage future space exploration, the researchers proposed a new way to watch for danger. Instead of waiting for a definitive answer that might take decades to arrive, they built a forward-looking system that acts like a set of traffic lights for risk. This system uses a method called Bayesian surveillance, which allows scientists to update their understanding as new data comes in, rather than just looking at the past. The researchers ran simulations to project the next ten years of the astronauts' lives, asking a specific question: how many future deaths would it take to trigger a warning that the risk is truly elevated?

For the male astronauts, the simulation showed that if the group were to see 17 or more deaths from these neurological causes over the next decade, the evidence would be strong enough to say with high confidence that the risk is significantly higher than normal. If the number of deaths remained low, specifically below a certain threshold, the data would suggest the risk is actually lower than average. For the female astronauts, the threshold was much lower due to the smaller group size; just three deaths in the next ten years would signal a potential excess risk. These boundaries are not fixed rules but dynamic lines that move as the astronauts age and the expected number of deaths naturally rises with time.

This approach transforms uncertainty into a clear, actionable plan. It acknowledges that with a small group of people, traditional statistics often fail to provide a clear answer, leaving scientists in a state of indecision. By defining exactly what future events would constitute a problem, the researchers provide a transparent tool for monitoring the health of the astronaut corps. The study concludes that while the current data does not show a spike in neurological deaths, the small size of the group means that definitive answers about deep-space risks may remain elusive for a long time. The value of this work lies not in solving the mystery today, but in establishing a rigorous, updatable framework that ensures that as the cohort ages and new data arrives, the scientific community will know exactly when to sound the alarm and when to remain reassured.